International Ophthalmology

, Volume 33, Issue 3, pp 227–236 | Cite as

Visual function after pars plana vitrectomy in macular edema with branch retinal vein occlusion

Original Paper

Abstract

The objective of this study is to evaluate functional and morphological changes of the macula after pars plana vitrectomy (PPV) for macular edema with branch retinal vein occlusion (BRVO). Eighteen patients with BRVO (mean age: 71.3 ± 5.9 years; six women and 12 men) received PPV. Macular function was documented by microperimetry and best-corrected visual acuity (BCVA) was determined. Retinal thickness and retinal volume were measured by optical coherence tomography (OCT), and mean retinal sensitivity was calculated for each of nine macular subfields. Ischemia and serous retinal detachment (SRD) were evaluated by fluorescein angiography and OCT, respectively. Mean BCVA was significantly improved at 3 and 6 months after PPV. Mean retinal sensitivity, retinal thickness, and retinal volume were significantly improved after 3 and 6 months in five, eight, and eight subfields, respectively. Improvement of visual acuity and the percent change in retinal thickness or retinal volume were not correlated in any of the nine subfields, while improvement of retinal sensitivity was correlated with the percent change in both retinal thickness and retinal volume in the temporal outer subfield. There were significant differences with respect to the percent changes in retinal thickness and volume in the temporal outer field between the non-ischemic and ischemic groups, as well as between the patients with and without SRD. There was also a significant difference between the non-ischemic and ischemic groups with respect to the improvement of retinal sensitivity in three out of nine fields. These findings suggest that PPV can improve both functional and morphological changes due to macular edema in BRVO patients, and that morphological improvement in the temporal outer subfield after PPV might influence the functional prognosis of these patients.

Keywords

Branch retinal vein occlusion Macular edema Retinal sensitivity Retinal thickness Retinal volume Pars plana vitrectomy 

Notes

Conflict of interest

None.

References

  1. 1.
    Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM (1996) Prognostic factors for retinal vein occlusion: prospective study of 175 cases. Ophthalmology 103:551–560PubMedGoogle Scholar
  2. 2.
    Noma H, Funatsu H, Sakata K et al (2009) Macular microcirculation and macular oedema in branch retinal vein occlusion. Br J Ophthalmol 93:630–633PubMedCrossRefGoogle Scholar
  3. 3.
    Noma H, Funatsu H, Yamasaki M et al (2005) Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 140:256–261PubMedCrossRefGoogle Scholar
  4. 4.
    Noma H, Minamoto A, Funatsu H et al (2006) Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 244:309–315PubMedCrossRefGoogle Scholar
  5. 5.
    Noma H, Funatsu H, Yamasaki M et al (2008) Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 22:42–48PubMedCrossRefGoogle Scholar
  6. 6.
    Kriechbaum K, Michels S, Prager F et al (2008) Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study. Br J Ophthalmol 92:518–522PubMedCrossRefGoogle Scholar
  7. 7.
    Prager F, Michels S, Kriechbaum K et al (2009) Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol 93:452–456PubMedCrossRefGoogle Scholar
  8. 8.
    Campochiaro PA, Heier JS, Feiner L et al (2010) Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 117:1102–1112 e1PubMedCrossRefGoogle Scholar
  9. 9.
    Scott IU, Ip MS, VanVeldhuisen PC et al (2009) A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 6. Arch Ophthalmol 127:1115–1128PubMedCrossRefGoogle Scholar
  10. 10.
    The Branch Vein Occlusion Study Group (1984) Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 98:271–282Google Scholar
  11. 11.
    Kumagai K, Furukawa M, Ogino N, Uemura A, Larson E (2007) Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion. Retina 27:49–54PubMedCrossRefGoogle Scholar
  12. 12.
    Yamaike N, Kita M, Tsujikawa A, Miyamoto K, Yoshimura N (2007) Perimetric sensitivity with the micro perimeter 1 and retinal thickness in patients with branch retinal vein occlusion. Am J Ophthalmol 143:342–344PubMedCrossRefGoogle Scholar
  13. 13.
    Yamaike N, Tsujikawa A, Sakamoto A et al (2009) Retinal sensitivity after intravitreal injection of bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. Retina 29:757–767PubMedCrossRefGoogle Scholar
  14. 14.
    Noma H, Funatsu H, Mimura T, Harino S, Shimada K (2011) Functional-morphologic correlates in patients with branch retinal vein occlusion and macular edema. Retina 31:2102–2108PubMedCrossRefGoogle Scholar
  15. 15.
    Chung EJ, Hong YT, Lee SC, Kwon OW, Koh HJ (2008) Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 246:1241–1247PubMedCrossRefGoogle Scholar
  16. 16.
    Rehak J, Dusek L, Chrapek O, Fric E, Rehak M (2010) Initial visual acuity is an important prognostic factor in patients with branch retinal vein occlusion. Ophthalmic Res 45:204–209PubMedCrossRefGoogle Scholar
  17. 17.
    Scott IU, Vanveldhuisen PC, Oden NL et al (2011) Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: standard care versus corticosteroid for retinal vein occlusion study report 10. Ophthalmology 118:345–352PubMedCrossRefGoogle Scholar
  18. 18.
    Kriechbaum K, Prager F, Geitzenauer W et al (2009) Association of retinal sensitivity and morphology during antiangiogenic treatment of retinal vein occlusion over one year. Ophthalmology 116:2415–2421PubMedCrossRefGoogle Scholar
  19. 19.
    Kirchhoff AC, Drum ML, Zhang JX et al (2008) Hypertension and hyperlipidemia management in patients treated at community health centers. J Clin Outcomes Manag 15:125–131PubMedGoogle Scholar
  20. 20.
    Battaglia Parodi M, Saviano S, Ravalico G (1999) Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 237:1024–1027PubMedCrossRefGoogle Scholar
  21. 21.
    Branch Vein Occlusion Study Group (1986) Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Arch Ophthalmol 104:34–41CrossRefGoogle Scholar
  22. 22.
    Vrabec F (1996) The temporal raphe of the human retina. Am J Ophthalmol 62:926–938Google Scholar
  23. 23.
    Pavlidis M, Stupp T, Hummeke M, Thanos S (2006) Morphometric examination of human and monkey retinal ganglion cells within the papillomacular area. Retina 26:445–453PubMedCrossRefGoogle Scholar
  24. 24.
    Stefansson E (2001) The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand 79:435–440PubMedCrossRefGoogle Scholar
  25. 25.
    Noma H, Funatsu H, Mimura T, Shimada K (2012) Functional-morphological changes after intravitreal injection of triamcinolone acetonide for macular edema with branch retinal vein occlusion. J Ocul Pharmacol Ther 28:231–236PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Hidetaka Noma
    • 1
  • Katsunori Shimada
    • 2
  • Tatsuya Mimura
    • 3
  1. 1.Department of Ophthalmology, Yachiyo Medical CenterTokyo Women’s Medical UniversityYachiyoJapan
  2. 2.Department of Hygiene and Public Health IITokyo Women’s Medical UniversityTokyoJapan
  3. 3.Department of OphthalmologyMedical Center East, Tokyo Women’s Medical UniversityTokyoJapan

Personalised recommendations